Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Charles T Makowski"'
Autor:
Sage B, Greenlee, Rachel M, Kenney, Charles T, Makowski, Elizabeth, Bulat, Indira, Brar, Susan L, Davis
Publikováno v:
Journal of Addiction Medicine. 17:104-107
The aim of the study is to evaluate the impact of inpatient substance use disorder (SUD) resources on outcomes of persons who inject stimulants and/or opioids (PWIDs) with infections.This retrospective cohort evaluated PWIDs hospitalized from July 1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc60e478154a6e5b6c1e3ef0cfd41f5
https://doi.org/10.1097/adm.0000000000001028
https://doi.org/10.1097/adm.0000000000001028
Autor:
Sage B. Greenlee, Tommy J. Parraga Acosta, Charles T. Makowski, Rachel M. Kenney, Mayur Ramesh, Jonathan D. Williams, George J. Alangaden
Publikováno v:
Transplant Infectious Disease. 24
This study seeks to describe inpatient antimicrobial use (AU) utilizing the National Healthcare Safety Network-AU (NHSN-AU) framework among solid organ transplant recipients (SOTr) within 12 months after transplant.This cross-sectional study included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b87716c9606e3ec0ff31c298970c8d
https://doi.org/10.1111/tid.13944
https://doi.org/10.1111/tid.13944
Autor:
Jenna Holzhausen, Long To, Charles T Makowski, Raymond Yost, Mona Ali, Christopher Giuliano, Denise Sutter, Nisha Patel, Claudia Hanni, Amy Pallisco, Whitney Gibson, Elizabeth Petrovitch
Publikováno v:
Blood Adv
Apixaban in patients with impaired renal function is supported by limited data. Landmark clinical trials evaluating apixaban in patients with atrial fibrillation and/or acute venous thromboembolism excluded patients with creatinine clearance (CrCl)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97dab137c5d270d70ab96f4789f6ee69
https://doi.org/10.1182/bloodadvances.2019000972
https://doi.org/10.1182/bloodadvances.2019000972
Publikováno v:
Hosp Pharm
Background: The purpose of this study was to evaluate the safety of administering high-dose daptomycin (HDD; > 6 mg/kg actual body weight) as a 2-minute intravenous (IV) push (IVP) compared to traditional 30-minute IV piggyback (IVPB) infusion. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e318c32f12419c32713054db33180f
https://doi.org/10.1177/0018578719897076
https://doi.org/10.1177/0018578719897076
Autor:
Mathew Jones, Susan L. Davis, Austin R Morrison, George J Alangaden, Ahman R. Ramadan, Rachel M. Kenney, Linoj Samuel, Charles T Makowski
Publikováno v:
Diagnostic microbiology and infectious disease. 102(1)
Background Diagnostic stewardship interventions can decrease unnecessary antimicrobial therapy and microbiology laboratory resources and costs. Methods This retrospective cross-sectional study evaluated factors associated with inappropriate initial c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f074cd4a9beb43df40b6342688531ae6
https://pubmed.ncbi.nlm.nih.gov/34768207
https://pubmed.ncbi.nlm.nih.gov/34768207
Publikováno v:
The Annals of pharmacotherapy. 55(2)
Background: The Impella is a percutaneous ventricular assist device (pVAD) that provides temporary hemodynamic support to patients with cardiogenic shock or for protected percutaneous coronary intervention. The manufacturer recommends a 50-U/mL conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a9c61ee86e89b2bafc9b143e726a4f
https://pubmed.ncbi.nlm.nih.gov/32741200
https://pubmed.ncbi.nlm.nih.gov/32741200
Publikováno v:
Open Forum Infectious Diseases
Background Intravenous (IV) base solution shortages pose issues in the administration of IV antimicrobials and necessitate alternative administration strategies. Safety data supports 2-minute infusions of IV daptomycin up to the labeled dose of 6 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f34a31f5addb7a12848f8c8bc89c36d
https://doi.org/10.1093/ofid/ofz360.827
https://doi.org/10.1093/ofid/ofz360.827
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 35:502-519
Riociguat is the first approved medication from the novel class of soluble guanylate cyclase (sGC) stimulators and the only agent approved for treating both chronic thromboembolic hypertension (CTEPH) and pulmonary arterial hypertension (PAH). The no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b54f64bd39f65be430cc9de065e35e
https://doi.org/10.1002/phar.1592
https://doi.org/10.1002/phar.1592
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(21)
The Food and Drug Administration Amendments Act was introduced in 2007, requiring manufacturers to develop and implement a risk evaluation and mitigation strategy (REMS) when a drug’s prescribing information alone does not ensure that the benefits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c0b9d7e4b59fe65318e1466c39f0dc
https://pubmed.ncbi.nlm.nih.gov/29070497
https://pubmed.ncbi.nlm.nih.gov/29070497
Publikováno v:
Open Forum Infectious Diseases
Background Attainable, low-resource antimicrobial stewardship (AMS) interventions, “low-hanging fruit” can be facilitated by electronic medical record (EMR) enhancements. Oral (PO) fluoroquinolone (FQ) or tetracycline (TCN) coadministration with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8819de756b04eee40ad92e59caf1ba2e
https://doi.org/10.1093/ofid/ofy210.205
https://doi.org/10.1093/ofid/ofy210.205